Adamis Pharmaceuticals competitorsClear all

Adamis Pharmaceuticals's top competitors include Acticor Biotech, Melinta Therapeutics, CTI BioPharma and Cardiorentis.
Adamis Pharmaceuticals
Adamis Pharmaceuticals
Adamis Pharmaceuticals Corporation is a specialty biopharmaceuticals company focused on developing and commercializing products in the therapeutic areas of allergy and respiratory disease.
Acticor Biotech
Acticor Biotech
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.
Melinta Therapeutics
Melinta Therapeutics
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
CTI BioPharma
CTI BioPharma
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.
Cardiorentis
Cardiorentis
Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases.
Founding Date
Founding Date
2006
Founding Date
2013
Founding Date
2000
Founding Date
1992
Founding Date
N/A
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
San Diego, US HQ
Locations
Paris, FR HQ
Locations
HQ
New Haven, US
Locations
Seattle, US HQ
Locations
Zug, CH HQ
Employees
Employees
15241% increase
Employees
14
Employees
2612% decrease
Employees
4621% decrease
Employees
N/A
Valuation ($)
Valuation ($)
68.8 m
Valuation ($)
N/A
Valuation ($)
24.6 m
Valuation ($)
49.5 m
Valuation ($)
N/A
Twitter followers
Twitter followers
121
Twitter followers
303
Twitter followers
344
Twitter followers
183
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
1415462
Alexa Website Rank
1172367
Alexa Website Rank
814950
Alexa Website Rank
796309
Alexa Website Rank
N/A

Financial

Revenue (est.)
Revenue (est.)
$15.1m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$26.3m (FY, 2018)
Revenue (est.)
N/A
Net income
Net income
($39m) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
($29.3m) (FY, 2018)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 16.4m
Total funding raised
$ 25.6m
Total funding raised
$ 519.2m
Total funding raised
$ 105m
Total funding raised
$ 118.5m
For sources of this data, please see the company profile

View company profiles

Acticor Biotech
HQ
Paris, FR
Employees
14

Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.

View company
Melinta Therapeutics
HQ
Employees
261↓ 2% decrease

Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.

View company
CTI BioPharma
HQ
Seattle, US
Employees
46↓ 21% decrease

CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.

View company
Cardiorentis
HQ
Zug, CH

Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases.

View company